LD-2 disclosure · 3rd Quarter - Report

AUTISM SPEAKS

3rd Quarter (July 1 - Sep 30) · 2015Posted Oct 20, 2015Filing document ↗LDA record ↗

Income$20Kfee reported

Client

2 issues

Taxation/Internal Revenue Code
ABLE Act (S313 and HR647 from 113th Congress) implementation issues with stakeholders.
LobbyistsKEVIN ROY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Health Issues
Autism CARES Act, HR 4631, implementation and general issues and awareness affecting autism research treatment and services. 21st Century Cures, HR 6, on issues affecting autism treatment development. Senate Innovation for Healthier Americans report and potential companion to HR 6. Precision Medicine Initiative. SSDI
LobbyistsKEVIN ROY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)

LD-2 disclosure · 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) · 2015Posted Oct 20, 2015Filing document ↗LDA record ↗

Income$20Kfee reported

2 issues

Taxation/Internal Revenue Code
ABLE Act (S313 and HR647 from 113th Congress) implementation issues with stakeholders.
LobbyistsKEVIN ROY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)
Health Issues
Autism CARES Act, HR 4631, implementation and general issues and awareness affecting autism research treatment and services. 21st Century Cures, HR 6, on issues affecting autism treatment development. Senate Innovation for Healthier Americans report and potential companion to HR 6. Precision Medicine Initiative. SSDI
LobbyistsKEVIN ROY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)